Diebold Nixdorf Inc
NYSE:DBD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Diebold Nixdorf Inc
NYSE:DBD
|
US |
|
Emperador Inc
XPHS:EMI
|
PH |
|
Forte Biosciences Inc
F:37T
|
US |
|
Bureau Veritas SA
PAR:BVI
|
FR |
|
DCI Indonesia Tbk PT
IDX:DCII
|
ID |
|
Murphy Oil Corp
NYSE:MUR
|
US |
|
1st Source Corp
NASDAQ:SRCE
|
US |
|
Rigel Pharmaceuticals Inc
NASDAQ:RIGL
|
US |
|
Arista Networks Inc
NYSE:ANET
|
US |
|
Albemarle Corp
NYSE:ALB
|
US |
|
J
|
JATT Acquisition Corp
F:1GU
|
KY |
|
Boot Barn Holdings Inc
NYSE:BOOT
|
US |
|
K
|
Klepierre SA
SWB:KPR
|
FR |
|
H
|
Halliburton Co
SWB:HAL
|
US |
|
H
|
Healthcare Realty Trust Inc
F:HR6
|
US |
|
V
|
Vodafone Group PLC
F:VODJ
|
UK |
|
E
|
Edgewell Personal Care Co
XMUN:EGZ
|
US |
|
I
|
Impala Platinum Holdings Ltd
SWB:IPHB
|
ZA |
|
B
|
Brandywine Realty Trust
F:B2X
|
US |
Wall St Price Targets
DBD Price Targets Summary
Diebold Nixdorf Inc
According to Wall Street analysts, the average 1-year price target for DBD is 100.3 USD with a low forecast of 95.95 USD and a high forecast of 105 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DBD's stock price target?
Price Target
100.3
USD
According to Wall Street analysts, the average 1-year price target for DBD is 100.3 USD with a low forecast of 95.95 USD and a high forecast of 105 USD.
What is the Revenue forecast for Diebold Nixdorf Inc?
Projected CAGR
4%
Over the last 4 years, the compound annual growth rate for Revenue has been -1%. The projected CAGR for the next 2 years is 4%.
What is the Operating Income forecast for Diebold Nixdorf Inc?
Projected CAGR
13%
Over the last 4 years, the compound annual growth rate for Operating Income has been 18%. The projected CAGR for the next 2 years is 13%.
What is the Net Income forecast for Diebold Nixdorf Inc?
Projected CAGR
58%
The compound annual growth rate for Net Income over the next 2 years is 58%.
